Structure provides a global network to standardize media strategy, buying and digital-search services
There is now a need “to think about and deliver solutions across a holistic media ecosystem—paid, earned owned, digital and traditional,”—and across a global geography, says Matt McNally, president of the newly structured Publicis Health Media (PHM) unit within Publicis Healthcare Communications Group (New York). The unit will work with pharma, health and wellness clients to deliver communications platforms across the growing diversity of communications channels relevant to healthcare: advertising, self-publishing, online search and related digital media and “traditional” communications, according to the company.
PHM draws on existing expertise within business units of Publicis, including the agencies Saatchi & Saatchi Health, Razorfish and Digitas Health, the Publicis Touchpoint Solutions field sales organization, as well as the parent, Publicis S.A. It will start out with a staff of around 120, and draw on media-buying and digital-content capabilities from within those agencies as well as a center of excellence in Paris. A key component of the strategy is to be able to tailor local media campaigns to the conditions of media practices within that locale. “Speaking broadly, the US is ahead of the rest of the world in things like social media, but behind some parts of the world in terms of communications technologies; for example, smartphone usage is much higher in Asia-Pacific than here,” says McNally. “There is a need to bridge that gap.”
Pharma companies are having a harder time managing global marketing campaigns, given that media and communication channels operate in different patterns in diverse parts of the world; while the content or messaging might be the same, the delivery platforms differ in their reach. “Today, media is changing faster than advertising is,” McNally sums up.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.